pX330.puro Citations (4)

Originally described in: HuR (ELAVL1) silencing sensitizes triple-negative breast cancer to glutaminase-targeted therapy
Sandra Martha Gomes Dias Unpublished

---

Articles Citing pX330.puro

Articles
The impact of VPS35 D620N mutation on alternative autophagy and its reversal by estrogen in Parkinson's disease. Shiraishi T, Bono K, Hiraki H, Manome Y, Oka H, Iguchi Y, Okano HJ. Cell Mol Life Sci. 2024 Feb 27;81(1):103. doi: 10.1007/s00018-024-05123-4. PubMed
Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients. Qiao X, van der Zanden SY, Li X, Tan M, Zhang Y, Song JY, van Gelder MA, Hamoen FL, Janssen L, Zuur CL, Pang B, van Tellingen O, Li J, Neefjes J. Mol Cancer. 2024 Jun 4;23(1):120. doi: 10.1186/s12943-024-02034-7. PubMed
gamma-secretase facilitates retromer-mediated retrograde transport. Takeo Y, Crite M, Mehmood K, DiMaio D. J Cell Sci. 2025 Feb 15;138(4):JCS263538. doi: 10.1242/jcs.263538. Epub 2025 Feb 20. PubMed
DAPE cloning with modified primers for producing designated lengths of 3' single-stranded ends in PCR products. Lee S, Kim H, Aqsa, Jeung K, Won M, Ro H. PLoS One. 2025 Feb 13;20(2):e0318015. doi: 10.1371/journal.pone.0318015. eCollection 2025. PubMed

If you have published an article using this material, please email us at to have your article added to this page.